Net loss to common stockholders of $3.8 million, or $0.04 per share. This compares with a net income of $0.8 million, or $0.02 per share in the prior year.
http://www.marketwire.com/press-release/cytomedix-reports-2012-fourth-quarter-and-full-year-financial-results-otcqx-cmxi-1769203.htm
http://www.marketwire.com/press-release/cytomedix-reports-2012-fourth-quarter-and-full-year-financial-results-otcqx-cmxi-1769203.htm
No comments:
Post a Comment